BlackBarn Capital Partners LP In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), BlackBarn Capital Partners LP reported 15 stock positions worth $306.4 million . Its top holding was Roivant Sciences (ROIV) at 21.7% of the portfolio, followed by Privia Health (PRVA, 8.9% ) and Diversified Healthcare Trust (DHC, 8.9% ). Compared with Q2 2025, it opened 1 new position, sold out of 6, added to 6 and reduced 7. The biggest buy was a new position in McGraw Hill (MH) and the biggest sale an exit from Intel (INTC).
Location NEW YORK, NY
CIK 0002010204
Portfolio Value $306.4M (Q3 2025) Holdings 15 stocks · $306.4M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q2 2025 ROIV Roivant Sciences Ltd. 4,400,000 $66.6M Reduce -4.9% PRVA Privia Health Group Inc. 1,090,382 $27.2M Add +45.4% DHC Diversified Healthcare Trust 6,150,000 $27.1M Reduce -1.6% NXT Nextpower Inc. filed as NEXTRACKER INC 350,000 $25.9M Add +12.9% AMRX Amneal Pharmaceuticals Inc. 2,189,452 $21.9M Reduce -36.5% NEE Nextera Energy Inc. 270,000 $20.4M Add +8.0% TEVA Teva Pharmaceutical-SP ADR 1,000,000 $20.2M Reduce -4.8% ACLS Axcelis Technologies Inc. 200,000 $19.5M Reduce -44.4% MOH Molina Healthcare Inc. 95,000 $18.2M Add +26.7% CCOI Cogent Communications Holdin 375,000 $14.4M Add +56.3% VKTX Viking Therapeutics Inc. 500,000 $13.1M Add +42.9% MH McGraw Hill Inc. 850,757 $10.7M New ABUS Arbutus Biopharma Corp. 2,000,000 $9.1M Reduce -23.2% FBLA FB Bancorp Inc. 624,700 $7.5M No change BVFL BV Financial Inc. filed as BV FINL INC 291,442 $4.7M Reduce -39.3%
Options reported separately and not counted above: SPY puts ($832.7M), RMD puts ($191.6M), WRBY puts ($27.6M), OSCR puts ($23.7M), ELAN puts ($15.1M).
Portfolio Sells Q2 2025 → Q3 2025 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2025 % Of Portfolio Change To Portfolio ▲ INTC Intel Corp. Sold out 0.00% −4.08 EGBN Eagle Bancorp Inc. Sold out 0.00% −3.44 BRBS Blue Ridge Bankshares Inc. Sold out 0.00% −2.82 AMRX Amneal Pharmaceuticals Inc. Reduce -36.5% 7.15% −2.09 ACLS Axcelis Technologies Inc. Reduce -44.4% 6.37% −1.94 HBNC Horizon Bancorp Inc. Sold out 0.00% −1.53 PRO Pros Holdings Inc. Sold out 0.00% −1.18 BVFL BV Financial Inc. Reduce -39.3% 1.53% −0.89 MODVQ Modivcare Inc. Sold out 0.00% −0.10 ABUS Arbutus Biopharma Corp. Reduce -23.2% 2.96% +0.30 TEVA Teva Pharmaceutical-SP ADR Reduce -4.8% 6.59% +0.76 DHC Diversified Healthcare Trust Reduce -1.6% 8.85% +1.44 ROIV Roivant Sciences Ltd. Reduce -4.9% 21.72% +4.45
Portfolio Buys Q2 2025 → Q3 2025 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2025 % Of Portfolio Change To Portfolio ▼ MH McGraw Hill Inc. New 3.48% +3.48 PRVA Privia Health Group Inc. Add +45.4% 8.86% +3.14 NXT Nextpower Inc. Add +12.9% 8.45% +2.87 VKTX Viking Therapeutics Inc. Add +42.9% 4.29% +1.21 NEE Nextera Energy Inc. Add +8.0% 6.65% +0.90 CCOI Cogent Communications Holdin Add +56.3% 4.69% +0.86 MOH Molina Healthcare Inc. Add +26.7% 5.93% −1.47
Options Activity Q2 2025 → Q3 2025 Security Type Change vs Q2 2025 Underlying Shares Value ▼ TSLA Tesla Inc. put Sold out 1,900,000 $603.6Mbefore exit RMD Resmed Inc. put New 700,000 $191.6M ARKK ARK Innovation ETF put Sold out 1,000,000 $70.3Mbefore exit WRBY Warby Parker Inc. Class A put New 1,000,000 $27.6M OSCR Oscar Health Inc. Class A put New 1,250,000 $23.7M ELAN Elanco Animal Health Inc. put New 750,000 $15.1M
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 17 $402.2M ROIV, PRVA, DHC, NEE, NIQ Q1 2026 14 $332.4M ROIV, VECO, PRVA, DHC, NEE Q4 2025 11 $278.9M ROIV, DHC, PRVA, NIQ, NEE Q3 2025 15 $306.4M ROIV, PRVA, DHC, NXT, AMRX Q2 2025 20 $301.8M ROIV, AMRX, ACLS, DHC, MOH Q1 2025 18 $292.8M ROIV, UNH, MOH, AMRX, ACLS Q4 2024 15 $254.1M ROIV, UNH, MOH, TEVA, AMRX Q3 2024 18 $230.1M ROIV, MOH, AMRX, DHC, T Q2 2024 17 $194.0M ROIV, UNH, MOH, AMRX, BRBS Q1 2024 21 $173.0M ROIV, MOH, UNH, CHRD, CF